Insider buying
~$1.18M244K sh @ $4.83
Traded May 20 · filed 2 days later
Since the trade −73.5% · S&P 500 −6.9% · to Nov 20
Bought 56% below the 52-week high, RSI 37, 26% under its 200-day average, 64 points behind the S&P 500 over 3 months
A Kalaris Therapeutics director paid $1.18M out of pocket for Kalaris Therapeutics shares.